Toh S - Search Results

1

Process guide for inferential studies using healthcare data from routine clinical practice to evaluate causal effects of drugs (PRINCIPLED): considerations from the FDA Sentinel Innovation Center.

Desai RJ, Wang SV, Sreedhara SK, Zabotka L, Khosrow-Khavar F, Nelson JC, Shi X, Toh S, Wyss R, Patorno E, Dutcher S, Li J, Lee H, Ball R, Dal Pan G, Segal JB, Suissa S, Rothman KJ, Greenland S, Hernán MA, Heagerty PJ, Schneeweiss S. Desai RJ, et al. Among authors: toh s. BMJ. 2024 Feb 12;384:e076460. doi: 10.1136/bmj-2023-076460. BMJ. 2024. PMID: 38346815 No abstract available.

2

Development and application of two semi-automated tools for targeted medical product surveillance in a distributed data network.

Connolly JG, Wang SV, Fuller CC, Toh S, Panozzo CA, Cocoros N, Zhou M, Gagne JJ, Maro JC. Connolly JG, et al. Among authors: toh s. Curr Epidemiol Rep. 2017 Dec;4(4):298-306. doi: 10.1007/s40471-017-0121-0. Epub 2017 Oct 6. Curr Epidemiol Rep. 2017. PMID: 29204333 Free PMC article.

3

Prospective surveillance pilot of rivaroxaban safety within the US Food and Drug Administration Sentinel System.

Chrischilles EA, Gagne JJ, Fireman B, Nelson J, Toh S, Shoaibi A, Reichman ME, Wang S, Nguyen M, Zhang R, Izem R, Goulding MR, Southworth MR, Graham DJ, Fuller C, Katcoff H, Woodworth T, Rogers C, Saliga R, Lin ND, McMahill-Walraven CN, Nair VP, Haynes K, Carnahan RM. Chrischilles EA, et al. Among authors: toh s. Pharmacoepidemiol Drug Saf. 2018 Mar;27(3):263-271. doi: 10.1002/pds.4375. Epub 2018 Jan 10. Pharmacoepidemiol Drug Saf. 2018. PMID: 29318683

4

Sequential surveillance for drug safety in a regulatory environment.

Martin D, Gagne JJ, Gruber S, Izem R, Nelson JC, Nguyen MD, Ouellet-Hellstrom R, Schneeweiss S, Toh S, Walker AM. Martin D, et al. Among authors: toh s. Pharmacoepidemiol Drug Saf. 2018 Jul;27(7):707-712. doi: 10.1002/pds.4407. Epub 2018 Mar 5. Pharmacoepidemiol Drug Saf. 2018. PMID: 29504168 No abstract available.

5

Extension of Disease Risk Score-Based Confounding Adjustments for Multiple Outcomes of Interest: An Empirical Evaluation.

Desai RJ, Wyss R, Jin Y, Bohn J, Toh S, Cosgrove A, Kennedy A, Kim J, Kim C, Ouellet-Hellstrom R, Karami S, Major JM, Niman A, Wang SV, Gagne JJ. Desai RJ, et al. Among authors: toh s. Am J Epidemiol. 2018 Nov 1;187(11):2439-2448. doi: 10.1093/aje/kwy130. Am J Epidemiol. 2018. PMID: 29947726

6

Evaluating automated approaches to anaphylaxis case classification using unstructured data from the FDA Sentinel System.

Ball R, Toh S, Nolan J, Haynes K, Forshee R, Botsis T. Ball R, et al. Among authors: toh s. Pharmacoepidemiol Drug Saf. 2018 Oct;27(10):1077-1084. doi: 10.1002/pds.4645. Epub 2018 Aug 28. Pharmacoepidemiol Drug Saf. 2018. PMID: 30152575

7

Evaluating the use of bootstrapping in cohort studies conducted with 1:1 propensity score matching-A plasmode simulation study.

Desai RJ, Wyss R, Abdia Y, Toh S, Johnson M, Lee H, Karami S, Major JM, Nguyen M, Wang SV, Franklin JM, Gagne JJ. Desai RJ, et al. Among authors: toh s. Pharmacoepidemiol Drug Saf. 2019 Jun;28(6):879-886. doi: 10.1002/pds.4784. Epub 2019 Apr 24. Pharmacoepidemiol Drug Saf. 2019. PMID: 31020732

8

Controlling Confounding in a Study of Oral Anticoagulants: Comparing Disease Risk Scores Developed Using Different Follow-Up Approaches.

Bohn J, Schneeweiss S, Glynn RJ, Toh S, Wyss R, Desai R, Gagne JJ. Bohn J, et al. Among authors: toh s. EGEMS (Wash DC). 2019 Jul 15;7(1):27. doi: 10.5334/egems.254. EGEMS (Wash DC). 2019. PMID: 31346542 Free PMC article.

9

Use of Time-Dependent Propensity Scores to Adjust Hazard Ratio Estimates in Cohort Studies with Differential Depletion of Susceptibles.

Wyss R, Gagne JJ, Zhao Y, Zhou EH, Major JM, Wang SV, Desai RJ, Franklin JM, Schneeweiss S, Toh S, Johnson M, Fireman B. Wyss R, et al. Among authors: toh s. Epidemiology. 2020 Jan;31(1):82-89. doi: 10.1097/EDE.0000000000001107. Epidemiology. 2020. PMID: 31569120

10

Understanding utilization patterns of biologics and biosimilars in the United States to support postmarketing studies of safety and effectiveness.

Dutcher SK, Fazio-Eynullayeva E, Eworuke E, Carruth A, Dee EC, Blum MD, Nguyen MD, Toh S, Panozzo CA, Lyons JG. Dutcher SK, et al. Among authors: toh s. Pharmacoepidemiol Drug Saf. 2020 Jul;29(7):786-795. doi: 10.1002/pds.4908. Epub 2019 Dec 11. Pharmacoepidemiol Drug Saf. 2020. PMID: 31828887

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

886 results

Search Page

Filters